ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

NCT05380557 · clinicaltrials.gov ↗

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Low site engagement and accrual

Conditions

Pancreatic Adenocarcinoma
Pancreatic Cancer
Resectable Pancreatic Cancer

Interventions

DIAGNOSTIC_TEST: Germline genetic testing

Sponsor

Invitae Corporation

Collaborators

[object Object]